[Clinical significance of the immunosuppressive effect of cyclophosphamide].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000917:Antibody Formation / Q000187:drug effects*; D000937:Antigen-Antibody Reactions; D003520:Cyclophosphamide / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006394:Hemangiosarcoma / Q000188:drug therapy; D006801:Humans; D007110:Immunity, Active; D007114:Immunization; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology*; D012516:Osteosarcoma / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy; D013584:Sarcoma, Synovial / Q000188:drug therapy; D013209:Staphylococcal Vaccines
D013209:Staphylococcal Vaccines; D003520:Cyclophosphamide
Zur kliischen Bedeutung des immunsuppressiven Effektes von Cyclophosphamid.